Asset Details
Do you wish to reserve the book?
Abatacept for Severe Immune Checkpoint Inhibitor–Associated Myocarditis
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Abatacept for Severe Immune Checkpoint Inhibitor–Associated Myocarditis
Do you wish to request the book?
Abatacept for Severe Immune Checkpoint Inhibitor–Associated Myocarditis
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Abatacept for Severe Immune Checkpoint Inhibitor–Associated Myocarditis
2019
Overview
Autoimmune myocarditis is a rare but often fatal complication of immune checkpoint inhibitor therapy for cancer. A case of glucocorticoid-refractory myocarditis in the course of nivolumab treatment for lung cancer was resolved with the use of the cytotoxic T-lymphocyte–associated antigen 4 (CTLA-4) agonist abatacept.
Publisher
Massachusetts Medical Society
Subject
